Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 1

Interventions

Cisplatin 41Radiotherapy 32Fluorouracil 14Paclitaxel 13Docetaxel 12Cetuximab 12Radiotherapy, Intensity-Modulated 9Carboplatin 8Immunohistochemistry 6Radiotherapy, Conformal 5Gene Expression Profiling 4Polymerase Chain Reaction 3In Situ Hybridization, Fluorescence 3Gemcitabine 3Chemotherapy, Adjuvant 3vandetanib 2Surgical Procedures, Operative 2Reverse Transcriptase Polymerase Chain Reaction 2Radiosurgery 2Pilocarpine 2Panitumumab 2Neoadjuvant Therapy 2Lapatinib 2Isotretinoin 2In Situ Hybridization 2Fluorodeoxyglucose F18 2Filgrastim 2Epoetin Alfa 2Drug Therapy 2Biopsy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Head and Neck Neoplasms × Proteins × Clear all
NCT01025518 2016-11-29

DAHANCA 25A: Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer Patients

Danish Head and Neck Cancer Group

Phase NA Completed
30 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡